Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

GSK On Track For Six Regulatory Submissions In The Second Half

Wed, 07/24/2019 - 12:51pm

R&D President Hal Barron outlined progress reenergizing GSK's pharma pipeline and highlighted the key milestones ahead in 2019 during the...

      Related Stories 

ViiV Says Latest Data Back Two-Drug Approach, Plans Year-End Fostemsavir Filing

Wed, 07/24/2019 - 10:36am

ViiV Healthcare research head tells Scrip she expects Dovalto’s latest data presentation should boost the two-drug regime’s uptake, and that...

      Related Stories 

Interview: Atox Aims For Reltecimod OK In 2020

Wed, 07/24/2019 - 8:27am

The Israeli biotech is eagerly awaiting Phase III data on its therapy for necrotizing soft tissue infections before the end...

      Related Stories 

Torrent Makes ‘Cautious’ Comeback With Losartan In US

Wed, 07/24/2019 - 4:50am

Torrent restarts sale of losartan in the US, exercising caution to ensure the API sourced is “impurity free.” Timely resolution...

      Related Stories 

Asia Executives On The Move: Changes At Pfizer, Lilly, Alexion, Healios

Tue, 07/23/2019 - 11:57pm

The coming of summer has brought a flurry of executive changes in the Asia-Pacific health sector. Pfizer China's head of...

      Related Stories 

Vadadustat Emerges As Japan HIF-PHI Leader With First Filing Globally

Tue, 07/23/2019 - 7:29pm

Competition intensifies in novel anemia therapy space in Japan with first filing globally for Akebia/Mitsubishi Tanabe’s contender vadadustat, which could...

      Related Stories 

Kleo Brings Small-Molecule Approach To IO With Three Technological Applications

Tue, 07/23/2019 - 2:24pm

Emerging Company Profile: Using IP licensed from Yale, Kleo is betting it can complement or replace existing immuno-oncology drugs, specifically...

      Related Stories 

Myovant Plans Q4 Uterine Fibroid Drug Filing In A Showdown With AbbVie

Tue, 07/23/2019 - 2:08pm

A second Phase III trial testing relugolix met its primary endpoint, putting Myovant in a tight race with AbbVie to...

      Related Stories 

Biogen Growth Continues, But Analysts Worry About Near-Term R&D Prospects

Tue, 07/23/2019 - 1:36pm

The biotech’s MS franchise led by Tecfidera grew strongly, while SMA therapy Spinraza dipped slightly, but Biogen maintains optimistic outlook...

      Related Stories 

Pimavanserin Fails In ENHANCE But Other CNS Uses Targeted

Tue, 07/23/2019 - 8:00am

Acadia halts evaluation of pimavanserin as a schizophrenia adjunct but continues study of effect on negative symptoms and in other...

      Related Stories 

Changes Encourage Celltrion And Nan Fung To Bet On China Biosimilars Opportunity

Mon, 07/22/2019 - 6:35pm

Despite increasing competition, Celltrion has leapt into China's growing biosimilar market through a joint venture with Nan Fung, and another...

      Related Stories 

Novartis Ceritinib India Case: Court Rebuke Amid Wait For Patent Decision

Mon, 07/22/2019 - 4:21pm

An Indian court has frowned upon Novartis and opponent Natco for seemingly delaying proceedings before the Controller General of Patents...

      Related Stories 

Lyrica Generics Launch, But Pfizer Has Been Bracing For The Hit

Mon, 07/22/2019 - 1:05pm

The first generic versions of Pfizer's blockbuster pain medicine pregabalin have launched in the US. Pfizer has guided investors the...

      Related Stories 

A New Day Dawns For Avastin

Mon, 07/22/2019 - 12:49pm

The launch of Mvasi will be the first biosimilar version of Avastin in the US, a huge blockbuster for Roche...

      Related Stories 

Product Sales, Pipeline & Biosimilar Timelines Key Themes For Roche 2Q

Mon, 07/22/2019 - 7:33am

Investors during Roche’s second-quarter update on Thursday will look for updates on coming biosimilar competition, promising pipeline assets, and the...

      Related Stories 

Pipeline Watch: Phase III Trials Announced For HIV Vaccine, RecAP And Tucatinib

Mon, 07/22/2019 - 6:41am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Pages